CNTO 95, a fully human monoclonal antibody that inhibits alphav integrins, has antitumor and antiangiogenic activity in vivo (Q40565012)
Jump to navigation
Jump to search
scientific article published on June 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CNTO 95, a fully human monoclonal antibody that inhibits alphav integrins, has antitumor and antiangiogenic activity in vivo |
scientific article published on June 2004 |
Statements
1 reference
CNTO 95, a fully human monoclonal antibody that inhibits alphav integrins, has antitumor and antiangiogenic activity in vivo (English)
1 reference
Mohit Trikha
1 reference
Zhao Zhou
1 reference
Jeffrey A Nemeth
1 reference
Qiming Chen
1 reference
Celia Sharp
1 reference
Eva Emmell
1 reference
Jill Giles-Komar
1 reference
Marian T Nakada
1 reference
1 June 2004
1 reference
1 reference
110
1 reference
3
1 reference
326-335
1 reference
Identifiers
1 reference
1 reference